The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
It is with great sadness that the Unit has learned of the death of one of our Trustees and good friend, Dr Richard Tiner.
Dr Tiner qualified from The Middlesex Hospital Medical School in 1974. He trained in General Practice in Taunton, Somerset and worked as a GP Principal in Taunton from 1980 – 1996. He was the Medical Director of the Association of the British Pharmaceutical Industry (ABPI) 1996-2009 and served on a number of influential committees and boards including: the UK Clinical Research Collaboration Board, the National Cancer Research Institute Board and the Medical Advisory Board of the General Practice Research Database (GPRD).
As our Trustee, Dr Tiner showed complete commitment to the work of the Unit, sharing his expertise and judgement on a broad spectrum of issues. Everyone who had the privilege of working with him experienced his warm, genuine and positive approach.
Dr Tiner will be remembered fondly and missed greatly by the Trustees, Director and staff of the Unit and our thoughts are with his family at this sad time.View our latest news
The Drug Safety Research Unit (DSRU) offers a range of Pharmacovigilance (PV) training courses suitable for those looking for a career in pharmacovigilance, seeking career progression or in a position that requires PV knowledge and understanding. Depending on specific interests and current knowledge, the team at the DSRU is able to recommend which of our training courses could help […]View all our latest questions